Have you discussed anything about targeted therapies? For example, how the different genetic makeup of some tumors are used to treat them. Keytruda comes to mind.
I see where he discusses it. He said it only works for a small group and not for him.
He’s mentions trying drugs that target EGFR mutations, which I believe tries to stop the blood supply to the tumor. Targeting specific protein receptors, like HER2 in breast cancer, seems to be promising.
https://www.keytruda.com/
Antibody drug conjugates also seem to be discussed often:
https://www.mdanderson.org/cancerwise/antibody-drug-conjugat...